Skip to main content Accessibility help
×
Home

Predictors of Mortality From Community-Onset Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae

  • Anucha Apisarnthanarak (a1), Pattarachai Kiratisin (a2) and Linda M. Mundy (a3)

Abstract

In a cohort study of 36 patients with community-onset extended-spectrum β-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae bloodstream infections, we found that predictors of mortality were community-onset infection with ESBL-producing K. pneumoniae pathogens (P = .02) and failure to receive an initial empirical regimen that included either β-lactam and β-lactamase–inhibitors or a carbapenem (P = .04).

Copyright

Corresponding author

Division of Infectious Diseases, Faculty of Medicine, Thammasat University Hospital, Pratumthani, Thailand, 12120 (anapisarn@yahoo.com)

References

Hide All
1.Apisarnthanarak, A, Kiratisin, P, Saifon, P, Kitphati, R, Dejsirilert, S, Mundy, LM. Clinical and molecular epidemiology of community-onset extended spectrum β-lactamase producing Escherichia coli in Thailand: a case-case-control study. Am J Infect Control 2007;35:606612.
2.Colodner, R, Rock, W, Chazan, B, et al. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163167.
3.Calbo, E, Romany, V, Xercavins, M, et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harboring extended-spectrum β-lactamases. J Antimicrob Chemother 2006;57:780783.
4.Rodriguez-Bano, J, Navarro, MD, Romero, L, et al. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006;43:14071414.
5.Apisarnthanarak, A, Kiratisin, P, Saifon, P, Kitphati, R, Dejsirilert, S, Mundy, LM. Predictors of mortality among patients with community-onset infection due to extended-spectrum β-lactamase-producing Escherichia coli in Thailand. Infect Control Hosp Epidemiol 2008;29:8082.
6.Garner, JS, Jarvis, WR, Emori, TG, et al. Centers for Disease Control definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.
7.Kollef, MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31(suppl4):S131138.
8.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing:17th informational supplement. Wayne, PA: CLSI; 2007:M100S17.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed